[1] Davis FG,Dolecek TA,Mccarthy BJ,et al.Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data[J].Neuro Oncol,2012,14(9):1171~1177.
[2] Smedby KE,Brandt L,Backlund ML,et al.Brain metastases admissions in Sweden between 1987 and 2006[J].Br J Cancer,2009,101(11):1919~1924.
[3] Soffietti R,Cornu P,Delattre JY,et al.EFNS Guidelines on diagnosis and treatment of brain metastases:report of an EFNS Task Force[J].Eur J Neurol,2006,13(7):674~681.
[4] Yamanaka R,Koga H,Yamamoto Y,et al.Characteristics of patients with brain metastases from lung cancer in a palliative care center.[J].Supportive care in cancer:official journal of the Multinational Association of Supportive Care in Cancer,2011,19(4).
[5] Stelzer KJ.Epidemiology and prognosis of brain metastases[J].Surg Neurol Int,2013,4(Suppl 4):S192~S202.
[6] Weller M,Stupp R,Wick W.Epilepsy meets cancer:when,why,and what to do about it?[J].Lancet Oncol,2012,13(9):e375~e382.
[7] Singh G,Rees J H,Sander J W.Seizures and epilepsy in oncological practice:causes,course,mechanisms and treatment[J].J Neurol Neurosurg Psychiatry,2007,78(4):342~349.
[8] 胡英春,孙作斌.以癫痫为首发症状的肺癌脑转移21例临床分析[J].癌症进展,2009,7(5):574~576.
[9] Oberndorfer S,Schmal T,Lahrmann H,et al.[The frequency of seizures in patients with primary brain tumors or cerebral metastases.An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology,Kaiser Franz Josef Hospital,Vienna] [J].Wien Klin Wochenschr,2002,114(21-22):911~916.
[10] Chan V,Sahgal A,Egeto P,et al.Incidence of seizure in adult patients with intracranial metastatic disease[J].J Neurooncol,2017,131(3):619~624.
[11] Wolpert F,Lareida A,Terziev R,et al.Risk factors for the development of epilepsy in patients with brain metastases[J].Neuro Oncol,2020,22(5):718~728.
[12] Skardelly M,Brendle E,Noell S,et al.Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors:A retrospective observational single center study[J].Ann Neurol,2015,78(6):917~928.
[13] Wu A,Weingart J D,Gallia G L,et al.Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors[J].World Neurosurg,2017,104:120~128.
[14] Ruda R,Mo F,Pellerino A.Epilepsy in brain metastasis:an emerging entity[J].Curr Treat Options Neurol,2020,22(2):6.
[15] Goldlust S A,Hsu M,Lassman A B,et al.Seizure prophylaxis and melanoma brain metastases[J].J Neurooncol,2012,108(1):109~114.
[16] Lee M H,Kong D S,Seol H J,et al.Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer[J].Acta Neurochir(Wien),2013,155(10):1833~1837.
[17] Cohen Z R,Suki D,Weinberg J S,et al.Brain metastases in patients with ovarian carcinoma:prognostic factors and outcome[J].J Neurooncol,2004,66(3):313~325.
[18] Borella F,Bertero L,Morrone A,et al.Brain Metastases from Ovarian Cancer:Current Evidence in Diagnosis,Treatment,and Prognosis[J].Cancers(Basel),2020,12(8).
[19] Tremont-Lukats I W,Bobustuc G,Lagos G K,et al.Brain metastasis from prostate carcinoma:The M.D.Anderson Cancer Center experience[J].Cancer,2003,98(2):363~368.
[20] Asano K,Hasegawa S,Matsuzaka M,et al.Brain tumor-related epilepsy and risk factors for metastatic brain tumors:analysis of 601 consecutive cases providing real-world data[J].J Neurosurg,2022,136(1):76~87.
[21] Maschio M,Dinapoli L,Gomellini S,et al.Antiepileptics in brain metastases:safety,efficacy and impact on life expectancy[J].J Neurooncol,2010,98(1):109~116.
[22] Bahna M,Heimann M,Bode C,et al.Tumor-associated epilepsy in patients with brain metastases:necrosis-to-tumor ratio forecasts postoperative seizure freedom[J].Neurosurg Rev,2022,45(1):545~551.
[23] Fox J,Ajinkya S,Greenblatt A,et al.Clinical characteristics,EEG findings and implications of status epilepticus in patients with brain metastases[J].J Neurol Sci,2019,407:116538.
[24] You G,Sha Z,Jiang T.The pathogenesis of tumor-related epilepsy and its implications for clinical treatment[J].Seizure,2012,21(3):153~159.
[25] Chen D Y,Chen C C,Crawford J R,et al.Tumor-related epilepsy:epidemiology,pathogenesis and management[J].J Neurooncol,2018,139(1):13~21.
[26] Soffietti R,Abacioglu U,Baumert B,et al.Diagnosis and treatment of brain metastases from solid tumors:guidelines from the European Association of Neuro-Oncology(EANO)[J].Neuro Oncol,2017,19(2):162~174.
[27] Chen CC,Rennert RC,Olson JJ.Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors[J].Neurosurgery,2019,84(3):E195~E197.
[28] 中国医师协会肿瘤医师分会,中国医疗保健国际交流促进会肿瘤内科分会.肺癌脑转移中国治疗指南(2021年版)[J].中华肿瘤杂志,2021,43(3):269~281.
[29] Glauser T,Ben-Menachem E,Bourgeois B,et al.Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.[J].Epilepsia,2013,54(3).
[30] Newton HB,Dalton J,Goldlust S,et al.Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.[J].Journal of neuro-oncology,2007,84(3).
[31] Benit CP,Vecht CJ.Seizures and cancer:drug interactions of anticonvulsants with chemotherapeutic agents,tyrosine kinase inhibitors and glucocorticoids[J].Neurooncol Pract,2016,3(4):245~260.
[32] Reddy JP,Dawood S,Mitchell M,et al.Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy[J].Radiother Oncol,2015,117(2):308~314.
[33] Cacho-Diaz B,San-Juan D,Salmeron K,et al.Choice of antiepileptic drugs affects the outcome in cancer patients with seizures[J].Clin Transl Oncol,2018,20(12):1571~1576.
[34] Puri PR,Johannsson B,Seyedi JF,et al.The risk of developing seizures before and after surgery for brain metastases[J].Clin Neurol Neurosurg,2020,193:105779.
[35] Garcia JH,Morshed RA,Chung J,et al.Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases[J].J Neurosurg,2022:1~8.
[36] Wong J,Hird A,Zhang L,et al.Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy[J].Int J Radiat Oncol Biol Phys,2009,75(4):1125~1131.
[37] Julie D,Ahmed Z,Karceski SC,et al.An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy[J].Seizure,2019,70:30~37.
[38] Carpentier A,Mcnichols RJ,Stafford RJ,et al.Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors[J].Neurosurgery,2008,63(1 Suppl 1):S21-S28,S28~S29.
[39] Riviere-Cazaux C,Bhandarkar A R,Rahman M,et al.Outcomes and principles of patient selection for laser interstitial thermal therapy(LITT) for metastatic brain tumor management:a multi-site,institutional case series[J].World Neurosurg,2022.
[40] Bastos D,Fuentes DT,Traylor J,et al.The use of laser interstitial thermal therapy in the treatment of brain metastases:a literature review[J].Int J Hyperthermia,2020,37(2):53~60.
[41] Salehi A,Kamath AA,Leuthardt EC,et al.Management of intracranial metastatic disease with laser interstitial thermal therapy[J].Front Oncol,2018,8:499. |
